With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

Quest Diagnostics Incorporated DGX recently completed the integration of Northeast regional operations to its new next-generation lab facility in Clifton, NJ. The facility is one of the largest ...

Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also ...

SECAUCUS, N.J. and BOSTON, June 11, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced ...

SECAUCUS, N.J. and INDIANAPOLIS, Aug. 3, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...

Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also ...

Corewell Health Southfield and Quest Diagnostics have completed a previously announced transaction to establish a laboratory ...

Corewell Health has signed on to a joint venture with Quest Diagnostics covering inpatient and outpatient lab management and the construction of a new 100,000-square-foot advanced lab facility. The ...

SECAUCUS, N.J. - Quest Diagnostics (NYSE: NYSE:DGX), a prominent provider of diagnostic information services, has announced the completion of its acquisition of select laboratory assets from ...

Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. The testing ...